🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06258863
Enrolling by invitation Observational

Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery

NCT06258863 · tracked via the Priya Life Science China tracker
Sponsor
Hubei Cancer Hospital
Phase
Observational
Started
2023-07-18
Last updated
2025-03-17

Condition(s) studied

Breast Neoplasm Female

Investigational drug(s) / intervention(s)

incision type

incision type: Total mastectomy was performed using one of the four incision types

Study summary

1. DATA COLLECTION: About 300 cases of female patients who underwent breast reconstruction at Hubei Cancer Hospital(HBCH) between February 2013 and June 2023 were retrospectively collected. The incision was defined as the mastectomy incision and was grouped by the commonly used inframammary fold incision, lateral chest wall incision, circumareolar incision, and radial incision. The incidence of postoperative incision-related complications was recorded for different incision types;
2. DATA ORGANIZATION: Patients were divided into subgroups based on history of previous breast surgery, location and size of the lump, retention of the nipple-areola complex, timing of reconstruction, and type of the implant. The correlation of each subgroup with incision design is discussed;
3. FOLLOW-UP: Collected cases were followed up by telephone to complete the Breast-Q questionnaire (aesthetic score);
4. DATA ANALYSIS: The incidence of postoperative incision-related complications and aesthetic scores for different incision types were statistically analyzed.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. total mastectomy 2. implant and/or autologous breast reconstruction. Exclusion Criteria: 1. No total mastectomy 2. loss of data or loss of follow-up 3. fatal cases

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hubei Cancer Hospital Wuhan Hongshan District

More Hubei Cancer Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06258863 on ClinicalTrials.gov ↗ ← All trials in China